Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/8068
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAgrawal, Y. K.-
dc.contributor.authorVaidya, Hitesh-
dc.contributor.authorBhatt, Hardik-
dc.contributor.authorManna, Kuntal-
dc.contributor.authorBrahmkshatriya, Pathik-
dc.date.accessioned2019-01-09T09:36:32Z-
dc.date.available2019-01-09T09:36:32Z-
dc.date.issued2007-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/8068-
dc.descriptionMedicinal Research Reviews, 2007en_US
dc.description.abstractVenous thromboembolic diseases are the major concern of rising cost of healthcare and are commonest health problem across the globe. Both genetic and acquired risk factors are believed to be strongly linked with these diseases. Commonly encountered problems to the therapy include dose fixing and routine monitoring yet some serious problems of bleeding also necessitates the immediate need to develop new agents. The review is primarily concerned with the new developments in the treatment of thromboembolic diseases. Therapeutic applications of anticoagulants, anti platelets, and thrombolytics have been discussed in enough detail.en_US
dc.publisherWiley Interscienceen_US
dc.relation.ispartofseriesIPFP0270;-
dc.subjectvenous thromboembolicen_US
dc.subjectantiplateletsen_US
dc.subjectthrombolyticsen_US
dc.subjectpharmacoeconomicsen_US
dc.titleRecent Advances in theTreatment ofThromboembolic Diseases: VenousThromboembolismen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0270.pdfIPFP0270319.74 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.